AMARYS
LIVE

Serial Number

79305303

Owner

Dr. Lydia Reutter

Attorney

SARA M. DORCHAK

Filing Date

Jan 18, 2021

Add to watchlist:

No watchlists yet
View on USPTO

AMARYS Trademark

Serial Number: 79305303 • Registration: 6920077

AMARYS is a trademark filed by Dr. Lydia Reutter on January 18, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 30 (Staple Foods). The application is currently registered and active.

Owner Contact Info

Dr. Lydia Reutter (6 trademarks)

Hirtenweg 10

Entity Type: 01

Trademark Details

Filing Date

January 18, 2021

Registration Date

December 13, 2022

Published for Opposition

April 26, 2022

Goods & Services

Plants and plant products as foodstuff, namely tea, processed herbs and spices; processed herbs; processed seeds for use as a seasoning; flavourings for foods, other than essential oils; coffee essences for food, other than essential oils; extracts used as food flavouring, not essential oils; dry seasoning mixess; dried herbs; mint, dried; spices; spices in the form of powders; marinades containing seasonings; condiments, namely chutneys and ketchup; herbal flavourings for making beverages, other than essential oils; cooking essences in the nature of cooking sauces; food flavourings being non-essential oils; flavourings of tea essences, other than essential oils, for food or beverages; processed seeds used as a flavouring for foods and beverages; seasoning mixes

Medical preparations and preparations of plant origin for use in naturopathy for the treatment of rheumatic diseases, fibromyalgia, chronic arthritis, Cytokine Release Syndrome, Systemic Inflammatory Response Syndrome, anemia, fatigue states, cancers, viral infections, stress-related diseases, sleep disorder, nervous restlessness, Attention Deficit Hyperactivity Disorder, mental illness, cognitive dysfunction, gastrointestinal inflammation, gastritis, inflammatory bowel disease, leaky gut syndromes, malabsorption, wound healing disorder, wound infection, and multidrug-resistant infections; pharmaceuticals and natural remedies for the treatment of rheumatic diseases, fibromyalgia, chronic arthritis, Cytokine Release Syndrome, Systemic Inflammatory Response Syndrome, anemia, fatigue states, cancers, viral infections, stress-related diseases, sleep disorder, nervous restlessness, Attention Deficit Hyperactivity Disorder, mental illness, cognitive dysfunction, gastrointestinal inflammation, gastritis, inflammatory bowel disease, leaky gut syndromes, malabsorption, wound healing disorder, wound infection, and multidrug-resistant infections; extracts of medicinal herbs; extracts of plants for medical use; extracts of medicinal plants; decoctions of plants for medical use; decoctions of medicinal herbs; plants extracts for medicinal use in dried or preserved form; medicinal herbs extracts in dried or preserved form; plant and herb extracts for medicinal use; plant extracts for pharmaceutical purposes; Processed medicinal plants being medicinal plant extracts featuring processed roots, tubers, stems, leaves, flowers, seeds and bark plant extracts, namely, stinging nettle, annual mugwort, lemon balm, hypericum, and yarrow, all in the nature of medicinal plant extracts; Processed parts of medicinal plants being medicinal plant extracts featuring processed in the nature of roots, tubers, stems, leaves, flowers, seeds and bark plant extracts, namely, stinging nettle, annual mugwort, lemon balm, hypericum, and yarrow, all in the nature of medicinal plant extracts; mixtures of medicinal plant extracts; nutritional supplements; dietary supplemental drinks; herbal supplements; nutraceuticals for use as a dietary supplement

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 24, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 31, 2023 FICS
FINAL DISPOSITION PROCESSED
Mar 31, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 13, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 13, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 13, 2022 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Nov 3, 2022 ETOP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 16, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 27, 2022 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 27, 2022 OPNR
EXTENSION OF TIME TO OPPOSE RECEIVED
May 24, 2022 ETOF
NOTIFICATION PROCESSED BY IB
May 9, 2022 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 26, 2022 NPUB
PUBLISHED FOR OPPOSITION
Apr 26, 2022 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 13, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 13, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 6, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 21, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 21, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 21, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 21, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 21, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 18, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 18, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 18, 2022 TROA
REFUSAL PROCESSED BY IB
Sep 4, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 19, 2021 RFCS
REFUSAL PROCESSED BY MPU
Aug 19, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 6, 2021 RFCR
NON-FINAL ACTION WRITTEN
Aug 5, 2021 CNRT
ASSIGNED TO EXAMINER
Jul 29, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 5, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 1, 2021 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Feb 25, 2021 SDRC